Company led drug alert - Duavive (conjugated oestrogen/bazedoxifene acetate) 0.45mg/20mg Modified Release Tablets – EU/1/14/960/001

As precautionary measure, Pfizer is recalling above batches from wholesalers due to out of spec results from ongoing stability studies. Tests of foil laminate pouch identified oxygen levels above specified limits, resulting in lower dissolution results for bazedoxifene acetate.

Medicines and Healthcare products Regulatory Agency